Use of circulating tumor DNA (ctDNA) for early assessment of treatment response in patients with non-small cell lung cancer (NSCLC): A real-world (RW) analysis incorporating baseline ctDNA level and molecular response

被引：0
|
作者：
Gordon, Sean
Losic, Bojan
Quinn, Katie
Chang, Kyle
Liao, Jiemin
Chuang, Han-Yu
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 07期
关键词：
D O I：
10.1158/1538-7445.AM2023-5573
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5573
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Cell-free circulating tumour DNA (ctDNA) in the management of patients with non-biopsiable advanced non-small cell lung cancer (NSCLC)
    Kushnir, M.
    Winter, H.
    Murias, C.
    Bains, P.
    Abbosh, C. Z.
    Papadatos-Pastos, D.
    Newsome-Davis, T.
    Ahmed, T.
    Swanton, C.
    Forster, M. D.
    Moore, D.
    Bennett, P.
    Faull, I.
    Lanman, R. B.
    Arkenau, H-T.
    ANNALS OF ONCOLOGY, 2018, 29
  • [32] Circulating tumor DNA (ctDNA) as a marker of minimal residual disease (MRD) in localized non-small cell lung carcinoma (NSCLC).
    Simon, Nicholas I.
    Davis, Andrew A.
    Mohindra, Nisha Anjali
    Villaflor, Victoria Meucci
    Chae, Young Kwang
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [33] Retrospective clinical analysis of circulating tumor DNA (ctDNA)-based molecular response (MR) and baseline blood-based tumor mutational burden (bTMB) for monitoring response in phase 3 trial of bintrafusp alfa vs. pembrolizumab treatment of non-small cell lung cancer (NSCLC)
    Feng, Zheng
    Machl, Andreas
    Wang, Danyi
    Overstreet, Brooke
    Yablonovitch, Arielle
    Scheuenpflug, Juergen
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [34] Early Response of Circulating Tumor DNA Predict the Efficacy of Nivolumab in Patients with Non-small Cell Lung Cancer
    Iijima, Yuki
    Hirotsu, Yosuke
    Amemiya, Kenji
    Mochizuki, Hitoshi
    Oyama, Toshio
    Nakagomi, Takahiro
    Uchida, Yoshinori
    Kobayashi, Yoichi
    Tsutsui, Toshiharu
    Kakizaki, Yumiko
    Goto, Taichiro
    Miyashita, Yoshihiro
    Omata, Masao
    CANCER SCIENCE, 2018, 109 : 920 - 920
  • [35] Circulating tumour DNA (ctDNA) in the clinical management of patients (pts) with advanced non-small cell lung cancer (NSCLC): A single centre experience
    Uccello, M.
    Kushnir, M.
    Mak, G.
    Henriquez, C. Murias
    Abbosh, C.
    Papadatos-Pastos, D.
    Newsom-Davis, T.
    Ahmad, T.
    Swanton, C.
    Forster, M.
    Lanman, R.
    Faull, I.
    Arkenau, H-T.
    ANNALS OF ONCOLOGY, 2017, 28
  • [36] Clinical application of ctDNA in early diagnosis, treatment and prognosis of patients with non-small cell lung cancer
    Zhu, Shenyu
    Wu, Rongqian
    Liu, Xiangjin
    Xie, Bin
    Xie, Chunfa
    Li, Shulin
    Wu, Zhicheng
    Zhang, Zuxiong
    Tang, Zhixian
    Gu, Liang
    FUTURE ONCOLOGY, 2024,
  • [37] Early assessment of therapy response in small cell lung cancer via longitudinal ctDNA analysis.
    Palma, John F.
    Woestmann, Corinna
    McNamara, Sylvie
    Hinzmann, Bernd
    Frohler, Sebastian
    Adams, Hans-Peter
    Feldkamp, Mirjam
    Siemann, Sandra
    Lange, Maria
    Blueher, Anja
    Yaung, Stephanie
    Xi, Liu
    Tikoo, Nalin
    Balasubramanyam, Aarthi
    Ju, Christine
    Pati, Amrita
    Wehnl, Birgit
    Muley, Thomas
    Ma, Xiaoju Max
    Herth, Felix
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [38] Next Generation Sequencing Of Solid Tumor And Circulating Tumor Dna (ctdna) For Real-Time Monitoring Of Metastatic Non-Small Cell Lung Cancer
    Thompson, J.
    Langer, C.
    Aggarwal, C.
    Bauml, J.
    Carpenter, E.
    Vachani, A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193
  • [39] Personalized tumor-informed circulating tumor DNA (ctDNA) analysis for molecular residual disease (MRD) detection in resected non-small cell lung cancer (NSCLC) with common driver genes
    Zhong, R.
    Liang, H.
    Jiang, Y.
    Lin, Y.
    Fu, W.
    Xiong, Y.
    Xiong, S.
    Wang, R.
    Ye, Z.
    Li, X.
    Li, J.
    Li, F.
    Wang, H.
    Xiang, Y.
    Yu, Z.
    Zhan, S.
    Chen, P.
    Zheng, X.
    Liang, W.
    He, J.
    ANNALS OF ONCOLOGY, 2023, 34 : S735 - S735
  • [40] Real-world analysis of the prognostic value of EGFR mutation detection in plasma ctDNA from patients with advanced non-small cell lung cancer
    Long, Chaolian
    Li, Kun
    Liu, Zichen
    Zhang, Nana
    Xing, Xuya
    Xu, Liming
    Gai, Fei
    Che, Nanying
    CANCER MEDICINE, 2023, 12 (07): : 7982 - 7991
12345